Article
Increased DHT levels in androgenic alopecia have been selected for to protect men from prostate cancer.
Medical hypotheses - 1 Apr 2014
Bhargava Shiva
Abstract excerpt
Androgenic alopecia, a condition characterized by increased levels of DHT could have been selected for due to the benefits that prostaglandin D2 (PGD(2)) has on the prostate. A DHT metabolite can increase the transcription of prostaglandin D2 synthase through estrogen receptor beta. The increase of PGD(2) can decrease the risk of prostate cancer and proliferation of prostate cancer cells. Therefore, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
